Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest hepatitis B Stories

2012-02-01 11:21:22

The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule being published February 1 in Annals of Internal Medicine (www.annals.org), the flagship journal of the American College of Physicians (ACP). In addition to the changes in the HPV vaccine, the ACIP now recommends vaccination...

Many High-risk Americans Don’t Get Hepatitis B Vaccine
2012-01-20 04:41:15

A recently published study investigating hepatitis B vaccination rates in the United States found that more than half of adults at risk for hepatitis B virus remain unvaccinated. With many of these individuals making contact with the healthcare system, including HIV testing, this statistic reflects many missed opportunities to vaccinate this population. Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the...

2011-12-22 13:23:00

EDMONTON, AB, Dec. 22, 2011 /PRNewswire/ - Compass Biotechnologies, Inc. (COBI:OB or "Compass") is a publically-traded specialty pharmaceutical company with a focus on building value in several key market areas - hepatitis anti-viral drugs and prophylactic vaccines, recombinant protein therapeutics called "biobetters", a diagnostics, cytokine reagents and growth factor supplements business for the research community and the biotech manufacturing industry, and a new women's healthcare...

2011-11-09 14:00:00

⢠96-week study in a population of nucleos(t)ide-naïve patients with chronic hepatitis B (CHB) infection ⢠Data presented at the American Association for the Study of Liver Diseases congress in San Francisco San Francisco, CA (PRWEB) November 09, 2011 Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week results from the BEâLOWâ“ž¢ study, a Phase IIIb clinical trial comparing...

2011-11-07 23:30:00

⢠Results add to data suggesting that SVR can be achieved with the combination of daclatasvir (BMS-790052) and asunaprevir (BMS-650032) in HCV genotype 1b patients ⢠Study expanded to include alfa/RBV ineligible or intolerant patients Princeton, NJ (PRWEB) November 07, 2011 Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a ten patient sentinel cohort of an ongoing Phase II study in which treatment with a dual, all-oral...

2011-11-07 17:02:13

Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study. Although infection with the hepatitis C virus increases health care costs overall, the specific impact of the disease´s progressive severity on health care costs has previously not been well studied. "The severity of hepatitis C-related liver disease increases with age, and the aging hepatitis C population is...

2011-11-07 09:30:00

DURHAM, N.C., Nov. 7, 2011 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, was presented with the "2011 SEBIO Deal of the Year: Venture Capital Transaction" award during a ceremony held at the conclusion of Southeast BIO's (SEBIO) 13th Annual Investor Forum on November 3, 2011. Kenneth I. Moch, President and Chief Executive Officer, and Timothy W. Trost, Senior Vice President and Chief Financial Officer, accepted the award on...

2011-11-07 07:10:00

SAN FRANCISCO, Nov. 7, 2011 /PRNewswire/ -- By examining 70,737 patients through institutional databases and medical charts, researchers at The University of Texas MD Anderson Cancer Center determined that only 20 percent of patients with newly diagnosed cancer who had hepatitis B virus (HBV) risk factors were screened for HBV infection before starting chemotherapy. This amount of screening is inadequate, according to Jessica P. Hwang, MD, MPH, the lead author of the study, "I hope my...

2011-11-05 08:00:00

HOERSHOLM, Denmark & SAN DIEGO, Nov. 5, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, presents new data from the Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was maintained for more than four weeks beyond the end...

2011-11-04 06:00:00

PRINCETON, N.J., Nov. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) and Bristol-Myers Squibb Company (NYSE: BMY) announced today the addition of four treatment arms to the ongoing Phase IIa trial evaluating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and Bristol-Myers Squibb Company's daclatasvir (BMS-790052), an investigational NS5A replication complex inhibitor, for the treatment of chronic hepatitis C (HCV). This trial is the result of a...


Latest hepatitis B Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

69_3e2a06a821d939ffdc2eab851bee21e9
2011-01-24 12:50:52

Hepatitis A, caused by hepatitis A virus, is an acute infectious disease of the liver that is transmitted person to person by ingestion of contaminated food or water or through direct contact with an infectious person. Millions of people are believed to become infected with HAV every year. The incubation period is two to six weeks and on average is 28 days. In less developed countries the HAV is usually contracted in early childhood. Clean water helps to decrease contraction of HAV. In 90%...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

0_9255b919f71eff1fd4202c1dbb1795d2
2011-01-12 15:49:29

Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...

More Articles (4 articles) »